Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 29020592

First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2017 Oct 12
First author
Lemery S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Lemery S
      type
      Author
    2. name
      Keegan P
      type
      Author
    3. name
      Pazdur R
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Lemery S
      type
      Author
    2. name
      Keegan P
      type
      Author
    3. name
      Pazdur R
      type
      Author
    bibliography ids
    1. nci-bib-a24b26f5ee13ac31679c8e7d
    book metadata
    content sha256
    67e707caf7b1b3e50b4675ff25e7b585234801120553be44109a12b8920aa070
    document type
    citation
    dois
    1. 10.1056/NEJMp1709968
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:29020592
    immutable id
    pubmed:29020592@67e707caf7b1b3e50b4675ff25e7b585234801120553be44109a12b8920aa070
    journal
    abbreviation
    N Engl J Med
    issn electronic
    1533-4406
    issn print
    0028-4793
    issue
    15
    name
    The New England journal of medicine
    nlm unique id
    0255562
    pages
    1409-1412
    volume
    377
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      29020592
      provenance
      batch id
      fb25b16edcb1373b70c1
      provider
      NCBI PubMed ESummary
      record sha256
      716e87e010a4d2d61e37c1f3f9dd7ef86e21371f7c1589919385d1ef0e0e2036
      response sha256
      182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
      retrieved at
      2026-09-09T23:47:28.490065+00:00
      publication date
      display
      2017 Oct 12
      precision
      day
      year
      2017
      publication types
      1. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/29020592/
      title
      First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication.

      Preserved source evidence · Independent clinical review pending · Not medical advice